The Role of Eosinophils in the Pathophysiology of Asthmaa
WILLIAM J. CALHOUN,
JULIE SEDGWICK,
WILLIAM W. BUSSE,
WILLIAM J. CALHOUN
Department of Medicine University of Wisconsin Madison, Wisconsin 53792
Search for more papers by this authorJULIE SEDGWICK
Department of Medicine University of Wisconsin Madison, Wisconsin 53792
Search for more papers by this authorCorresponding Author
WILLIAM W. BUSSE
Department of Medicine University of Wisconsin Madison, Wisconsin 53792
Dr. William W. Busse, University of Wisconsin Hospital, H6/360 CSC, 600 Highland Avenue, Madison, WI 53792.Search for more papers by this authorWILLIAM J. CALHOUN,
JULIE SEDGWICK,
WILLIAM W. BUSSE,
WILLIAM J. CALHOUN
Department of Medicine University of Wisconsin Madison, Wisconsin 53792
Search for more papers by this authorJULIE SEDGWICK
Department of Medicine University of Wisconsin Madison, Wisconsin 53792
Search for more papers by this authorCorresponding Author
WILLIAM W. BUSSE
Department of Medicine University of Wisconsin Madison, Wisconsin 53792
Dr. William W. Busse, University of Wisconsin Hospital, H6/360 CSC, 600 Highland Avenue, Madison, WI 53792.Search for more papers by this authora
This work was supported by funds from the following United States Public Health Service, National Institutes of Health grants: A1 266609, A1 23181, and HI. 44098.
REFERENCES
- 1 Wardlaw, A. J. & A. B. Kay. 1987. The role of the eosinophil in the pathogenesis of asthma. Allergy 42: 321–335.
- 2 Venge, P., L. Håkansson & C. G. B. Peterson. 1987. Eosinophil activation in allergic disease. Int. Arch. Allergy Appl. Immunol. 82: 333–337.
- 3 Frigas, E. & G. J. Gleich. 1986. The eosinophil and the pathophysiology of asthma. J. Allergy Clin. Immunol. 77: 527–537.
- 4 Gleich, G. J. 1990. The eosinophil and bronchial asthma: current understanding. J. Allergy Clin. Immunol. 85: 422–436.
- 5 Horn, R. B., E. D. Robin, J. Theodore & A. Van Kessel. 1975. Total eosinophil counts in the management of bronchial asthma. N. Engl. J. Med. 292: 1152–1155.
- 6 Bousquet, J., D. Chanez, J. Y. Lacoste, G. Barneòu, N. Ghavanian, I. Enhander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard & F-B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323: 1033–1039.
- 7
Williams, D. A. &
J. G. Leopold. 1959. Death from bronchial asthma.
Acta Allergol.
14: 83–86.
10.1111/j.1398-9995.1959.tb02814.x Google Scholar
- 8 Bailgelman, W., S. Chodosh, D. Pizzuto & L. A. Cupples. 1983. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbation of asthma. Am. J. Med. 25: 929–936.
- 9 Frew, A. J. & A. B. Kay. 1990. Eosinophils and T-lymphocytes in late-phase allergic reactions. J. Allergy Clin. Immunol. 85: 533–539.
- 10 Townley, R. G., R. J. Hopp, D. K. Agrawel & A. K. Bewtra. 1989. Platelet-activating factor and airway reactivity. J. Allergy Clin. Immunol. 83: 997–1010.
- 11 Gleich, G. J., N. A. Flavahan, T. Fujisawa & P. M. Vanhoutte. 1988. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial reactivity. J. Allergy Clin. Immunol. 81: 776–781.
- 12 Frigas, E. D., D. A. Loegering, G. O. Solley, G. M. Farrow & G. J. Gleich. 1981. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin. Proc. 56: 345–353.
- 13 Flavahan, N. A., N. R. Slifman, G. J. Gleich & P. M. Vanhoutte. 1988. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle: role of epithelium. Am. Rev. Respir. Dis. 138: 685–688.
- 14 Fukuda, T. & G. J. Gleich. 1989. Heterogeneity of human eosinophils. J. Allergy Clin. Immunol. 83: 369–373.
- 15 Fukuda, T., S. C. Dunnette, C. E. Reed, S. J. Ackerman, M. S. Peters & G. J. Gleich. 1985. Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma. Am. Rev. Respir. Dis. 132: 981–985.
- 16 Schult, P. A., M. Lega, S. Jadidi, R. Vrtis, T. Warner, F. M. Graziano & W. W. Busse. 1988. The presence of hypodense eosinophils and diminished chemiluminescence response in asthma. J. Allergy Clin. Immunol. 81: 429–437.
- 17 Frick, W. E., J. B. Sedgwick & W. W. Busse. 1988. Hypodense eosinophils in allergic rhinitis. J. Allergy Clin. Immunol. 82: 119–125.
- 18 Frick, W. E., J. B. Sedgwick & W. W. Busse. 1989. The appearance of hypodense eosinophils in antigen-dependent late phase asthma. Am. Rev. Respir. Dis. 139: 1401–1406.
- 19 Prin, L., J. Charon, M. Capron, P. L. Gosset, H. Taelman, A. B. Tonnel & A. Capron. 1984. Heterogeneity of human eosinophils. Variability of respiratory burst activity related to cell density. Clin. Exp. Immunol. 57: 735–742.
- 20 Lieferman, K. M., T. Fujisawa, B. H. Gray & G. L. Gleich. 1990. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction. Lab. Invest. 62: 579–589.
- 21 Clutterbuck, E. J., E. M. A. Hurst & C. J. Sanderson. 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM CSF. Blood 73: 1504–1512.
- 22 Lopez, A. F., C. J. Sanderson, J. R. Gamble, H. D. Campbell, I. G. Young & M. A. Vadas. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167: 219–224.
- 23 Yamaguchi, Y., Y. Hayashi, Y. Sugama, Y. Miura, T. Kasahara, S. Kitamura, M. Torisu, S. Mita, A. Tominaga, K. Tokatsu & T. Suda. 1988. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J. Exp. Med. 167: 1737–1742.
- 24 Rothenberg, M. E., J. Petersen, R. L. Stevens, D. S. Silberstein, D. T. McKenzie, K. F. Austen & W. F. Owen, Jr. 1989. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity and sustained antibody dependent cytotoxicity. J. Immunol. 143: 2311–2316.
- 25 Plaut, M., J. H. Pierce, C. J. Watson, J. Hanley-Hyde, R. P. Nordon & W. E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores. Nature 339: 64–67.
- 26 Burd, P. R., H. W. Rogers, J. R. Gordon, C. A. Martin, S. Jayaraman, S. D. Wilson, A. M. Dvorak, S. J. Galli & M. E. Dorf. 1989. Interleukin 3-dependent and independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170: 245–257.
- 27 Wodnar-Filspowicz, A., C. H. Heusser & C. Moroni. 1989. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 339: 150–152.
- 28 Lemanske, R. F. & M. A. Kaliner. 1988. Late phase allergic responses. In Allergy: Principles and Practice. E. Middleton, C. E. Reed, E. F. Ellis, N. F. Adkinson & J. W. Yunginger, Eds. 224–246. C.V. Mosby Co./ St. Louis .
- 29 de Monchy, J. G. R., H. F. Kauffman, P. Venge, G. H. Koeter, H. M. Jansen, H. J. Sluiter & K. de Vries. 1985. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 181: 373–376.
- 30 Chai, H., R. Farr & L. A. Froehlich. 1975. Standardization of bronchial inhalation challenge procedures. J. Allergy Clin. Immunol. 56: 323–327.
- 31 Bowsher, R. R., K. M. Verurg & D. P. Henry. 1983. Rat histamine N-methyl-transferase: quantitation, tissue distribution, purification, and immunologic properties. J. Biol. Chem. 258: 12215–12220.
- 32 Schwartz, L. B., T. R. Bradford, D. G. Lee & J. F. Chlebowski. 1990. Immunologic and physiochemical evidence for conformational changes occurring on conversion of human mast cell tryptase from active tetramer to inactive monomer: production of monoclonal antibodies recognizing active tryptase. J. Immunol. 144: 2304–2311.
- 33 Wenzel, S. E., A. A. Irani, J. M. Sanders, T. R. Bradford & L. B. Schwartz. 1986. Immunoassay of tryptase from human mast cells. J. Immunol. Methods 86: 139–142.
- 34 Naclerio, R. M., D. Proud, A. G. Togias, N. F. Adkinson, D. A. Meyers, A. Kagey-Sobotka, M. Plaut, P. S. Norman & L. M. Lichtenstein. 1985. Inflammatory mediators in late antigen-induced rhinitis. N. Engl. J. Med. 313: 65–70.
- 35 Warner, J. A., M. M. Pienkowski, M. Plaut, P. S. Norman & L. M. Lichtenstein. 1986. Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reaction. J. Immunol. 136: 2583–2587.
- 36 Reshef, A., A. Kagey-Sobotka, N. F. Adkinson, L. M. Lichtenstein & P. S. Norman. 1989. The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR). J. Allergy Clin. Immunol. 84: 678–687.
- 37 Wassom, D. L., D. A. Loegering, G. O. Solley, S. B. Moore, R. T. Schooley, A. S. Fauci & G. J. Gleich. 1981. Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J. Clin. Invest. 67: 651–661.
- 38 Maddox, D. E., J. A. Butterfield, S. J. Ackerman, C. B. Coulman & G. J. Gleich. 1983. Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein. J. Exp. Med. 158: 1211–1220.
- 39 Ackerman, S. J., D. A. Loegering, P. Venge, L. Olsson, J. B. Harley, A. S. Fauci & G. J. Gleich. 1983. Distinctive cationic proteins of the human eosinophil granule; major basic protein, eosinophilic cationic protein, and eosinophil-derived neurotoxin. J. Immunol. 131: 2977–2982.
- 40 Bacchetta, R., R. de Waal Malefijt, H. Yssel, J. Abrams, J. E. de Vries, H. Spits & M. G. Roncarolo. 1990. Host-reactive CD4+ and CD8+ T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-γ, and granulocyte/macro-phage-colony stimulating factor, but not IL-4. J. Immunol. 144: 902–908.
- 41 Limaye, A. P., J. S. Abrams, J. E. Silver, E. A. Ottesen & T. B. Nutman. 1990. Regulation of helminth-induced eosinophilia: Selectively increased interletikin-5 production by eosinophilic individuals. J. Exp. Med. 172: 399–402.
- 42 Owen, W. F., Jr., J. Peterson, D. M. Sheff, R. D. Folkerth. R. J. Anderson & J. M. Corson. 1990. Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome. Proc. Natl. Acad. Sci. USA 87: 8647–8651.
